News

Filter

Current filters:

EnbrelLicensing

Baxter and Coherus in up to $246 million deal for biosimilar etanercept

04-09-2013

US companies Baxter International (NYSE:BAX) and Coherus Biosciences have entered into an exclusive collaboration…

AmgenAnti-Arthritics/RheumaticsBaxter InternationalBiotechnologyCoherus BioSciencesEnbreletanerceptGenericsLicensingResearch

Takeda loses distribution of 13 Pfizer products in Japan

19-06-2012

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) has concluded an agreement that, as of December…

Asia-PacificBenefixEnbrelLicensingMarkets & MarketingPfizerPharmaceuticalPrevenarTakeda Pharmaceuticals

Merck & Co links with Korea’s Hanwha on biosimilar of Enbrel

14-06-2011

US drugs giant Merck & Co (NYSE:MRK) and South Korean drugmaker Hanwha Chemical Corp (KOSPI: 09830) have…

AmgenAnti-Arthritics/RheumaticsBiotechnologyEnbrelHanwha ChemicalLicensingMerck & CoPfizerPharmaceuticalResearchTakeda Pharmaceuticals

Back to top